William Von Mueffling Thermo Fisher Scientific Inc. Transaction History

Cantillon Capital Management LLC

$14.8 Billion
Q4 2024

A detailed history of William Von Mueffling (Cantillon Capital Management LLC) transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Cantillon Capital Management LLC holds 929,870 shares of TMO stock, worth $495 Million. This represents 3.27% of its overall portfolio holdings.

Number of Shares

929,870

Previous 799,000 16.38%

Holding current value

$495 Million

Previous $494 Million 2.12%

% of portfolio

3.27%

Previous 3.27%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$501.29 - $612.85 $65.6 Million - $80.2 Million	130,870 Added 16.38%	929,870 $484 Million
Q3 2024 Nov 07, 2024	SELL	$531.86 - $624.21 $12.7 Million - $14.9 Million	-23,838 Reduced 2.9%	799,000 $494 Million
Q2 2024 Aug 05, 2024	SELL	$541.52 - $599.02 $22.7 Million - $25.1 Million	-41,876 Reduced 4.84%	822,838 $455 Million
Q1 2024 May 08, 2024	SELL	$528.82 - $599.43 $9.15 Million - $10.4 Million	-17,303 Reduced 1.96%	864,714 $503 Million
Q4 2023 Feb 07, 2024	SELL	$431.41 - $532.94 $9.38 Million - $11.6 Million	-21,746 Reduced 2.41%	882,017 $468 Million
Q3 2023 Nov 06, 2023	SELL	$498.29 - $574.41 $1.72 Million - $1.98 Million	-3,451 Reduced 0.38%	903,763 $457 Million
Q2 2023 Aug 09, 2023	BUY	$508.46 - $591.13 $44.3 Million - $51.5 Million	87,092 Added 10.62%	907,214 $473 Million
Q1 2023 May 04, 2023	SELL	$535.0 - $604.82 $7.93 Million - $8.97 Million	-14,827 Reduced 1.78%	820,122 $473 Million
Q4 2022 Feb 06, 2023	SELL	$484.71 - $571.37 $7.99 Million - $9.42 Million	-16,490 Reduced 1.94%	834,949 $460 Million
Q3 2022 Nov 03, 2022	SELL	$507.19 - $604.49 $3.43 Million - $4.09 Million	-6,767 Reduced 0.79%	851,439 $432 Million
Q2 2022 Aug 03, 2022	SELL	$500.9 - $612.21 $2.35 Million - $2.87 Million	-4,695 Reduced 0.54%	858,206 $466 Million
Q1 2022 May 03, 2022	BUY	$524.0 - $644.92 $12.9 Million - $15.9 Million	24,611 Added 2.94%	862,901 $510 Million
Q4 2021 Jan 27, 2022	SELL	$569.0 - $667.24 $35.8 Million - $42 Million	-62,921 Reduced 6.98%	838,290 $559 Million
Q3 2021 Oct 26, 2021	SELL	$509.53 - $609.78 $7.88 Million - $9.43 Million	-15,459 Reduced 1.69%	901,211 $515 Million
Q2 2021 Jul 27, 2021	SELL	$441.0 - $508.24 $5.62 Million - $6.47 Million	-12,734 Reduced 1.37%	916,670 $462 Million
Q1 2021 May 03, 2021	SELL	$439.85 - $518.83 $15.3 Million - $18.1 Million	-34,796 Reduced 3.61%	929,404 $424 Million
Q4 2020 Feb 03, 2021	SELL	$435.06 - $527.66 $2.08 Million - $2.52 Million	-4,781 Reduced 0.49%	964,200 $449 Million
Q3 2020 Oct 30, 2020	SELL	$359.77 - $441.52 $4.27 Million - $5.24 Million	-11,867 Reduced 1.21%	968,981 $428 Million
Q2 2020 Jul 31, 2020	BUY	$275.2 - $362.34 $2.84 Million - $3.74 Million	10,323 Added 1.06%	980,848 $355 Million
Q1 2020 Apr 30, 2020	SELL	$255.3 - $340.05 $320,656 - $427,102	-1,256 Reduced 0.13%	970,525 $275 Million
Q4 2019 Feb 07, 2020	SELL	$271.93 - $328.04 $5.73 Million - $6.92 Million	-21,083 Reduced 2.12%	971,781 $316 Million
Q3 2019 Nov 04, 2019	SELL	$268.46 - $305.43 $2.18 Million - $2.48 Million	-8,117 Reduced 0.81%	992,864 $289 Million
Q2 2019 Jul 26, 2019	SELL	$257.51 - $295.55 $5.35 Million - $6.14 Million	-20,764 Reduced 2.03%	1,000,981 $294 Million
Q1 2019 May 01, 2019	SELL	$212.17 - $273.72 $675,761 - $871,798	-3,185 Reduced 0.31%	1,021,745 $280 Million
Q4 2018 Feb 05, 2019	BUY	$208.47 - $251.98 $102 Million - $123 Million	489,081 Added 91.27%	1,024,930 $229 Million
Q3 2018 Nov 09, 2018	BUY	$205.57 - $244.32 $110 Million - $131 Million	535,849 New	535,849 $131 Million

Others Institutions Holding TMO

# of Institutions

2,892

Shares Held

342M

Call Options Held

2.09M

Put Options Held

2.73M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $209B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track William Von Mueffling's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantillon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cantillon Capital Management LLC and William Von Mueffling with notifications on news.

Account